Why can short sellers publish manipulating garbage
Shareholders are entitled to know why the shares are under attack.
It has nothing to do with manipulation, but with a CEO misrepresenting
the sole therapy that it is currently marketing.
The point I was attempting to make was that the company
should have offered a secondary and used the proceeds to diversify
Mr. Beer did nothing and shareholders are paying the price.
I'm, definitely, no fan of $AEGR CEO Marc Beer, but a secondary offering would further dilute our shares, which is the last thing anybody should want? AEGR does have one other drug candidate, but I hear no talk of its development. I'd like to hear though about the plan to replace Marc Beer. How do you get that on the proxy?